Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired …
The HIV League Scholarship — the only national scholarship for students living with HIV — is accepting applications for the 2022 round until January 31 at 11:59 p.m. Eastern Time.
Here are the criteria for an individual to …
SPRINGFIELD, Ill.–Illinois HIV Care Connect today reached out to the Illinois Spanish-speaking population by featuring two organizations that are representative of how Illinois helps this community to prevent and provide care for HIV.
…“HIV innovation is occurring among
…